Sclerotherapy for venous malformations

H. Mimura, K. Shibamoto, Y. Soda, K. Kojima, Y. Matsui, H. Fujiwara, T. Hiraki, H. Gobara, S. Kanazawa

Research output: Contribution to journalArticlepeer-review

Abstract

Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.

Original languageEnglish
Pages (from-to)524-532
Number of pages9
JournalJapanese Journal of Clinical Radiology
Volume59
Issue number4
Publication statusPublished - Apr 2014
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Sclerotherapy for venous malformations'. Together they form a unique fingerprint.

Cite this